BMS361 Molecular Pathology (6)

In this subject students will draw together the knowledge gained in their study of physiology, biochemistry, human genetics and cell biology, haematology and histopathology to examine the molecular basis of disease. This subject will take a multi-disciplinary approach to the topic and focus on the application of molecular techniques to assist in the diagnosis of disease in a medical laboratory setting and how these techniques can be used to assist in the diagnosis and treatment of emerging diseases.

No offerings have been identified for this subject in 2021.

Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System



One session


School of Biomedical Sciences



Subject Relationships

BMS352 BMS361 is equivalent to BMS352 without the laboratory practicals

Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to describe the molecular basis of diseases relevant to medical laboratory scientists;
  • be able to explain how cytogenetics may be used in the diagnosis of disease;
  • be able to evaluate the practice of ''molecular medicine'' and the translational aspects of molecular pathology: molecular diagnostics, molecular assessment, and personalised medicine;
  • be able to justify the use of a particular diagnosis technique within a pathology setting and explain both the benefits and limitations of the technique; and
  • be able to critically evaluate and justify the use of molecular techniques in the diagnosis and treatment of disease by constructing a focused literature review.


This subject will cover the following topics:
  • Introduction to the subject (revision);
  • Molecular techniques in the diagnosis of disease: DNA related technologies (including example of disease);
  • Molecular techniques in the diagnosis of disease: RNA related technologies (including examples of disease);
  • Molecular techniques in the diagnosis of disease: Protein related technologies (including examples of disease);
  • Practice of molecular medicine;
  • Molecular assessment of human disease in the clinical laboratory; and
  • Pharmacogenomics and personalised medicine in the treatment of human disease.

The information contained in the CSU Handbook was accurate at the date of publication: May 2021. The University reserves the right to vary the information at any time without notice.